It is known that the Nrf2/Keap1 pathway is not only directly involved in the prevention of IBDs but also in the prevention of CD- and UC-related complications, such as intestinal fibrosis and colorectal cancer. The gene discussed is NFE2L2; the disease is colorectal cancer.